Literature DB >> 29887688

Correlation of Pattern of Spread and Outcomes in Advanced Epithelial Ovarian Cancers.

Amrutha Ramachandran1, Anupama Rajanbabu1, Kiran Gulabrao Bagul1, Keechilat Pavithran2, Dehannathparambil K Vijaykumar1.   

Abstract

The purpose of this study was to correlate the pattern of spread with oncological outcomes in advanced ovarian cancer patients. This is a retrospective analysis of 55 consecutive patients who had advanced epithelial ovarian cancer or primary peritoneal carcinomatosis (stages 3C and 4) with primary surgical intervention as the initial modality of treatment. Based on the spread of disease, they were further classified into class A: disease confined to the pelvis (excluded); class B: disease extending to the lower abdomen and omentum; class C: diffuse small-bowel disease with or without A, B, or D; and class D: disease in the upper abdomen. There were 17 patients (30.9%) in class B, 17 (30.9%) in class C, and 21 (38.2%) in class D. The number of patients with suboptimal cytoreduction was highest in class C (six patients). At the end of follow-up (median 38.6 months), 16 patients had no evidence of disease and 26 patients were alive with disease. The 3-year overall survival rates in classes B, C, and D were 94.1, 52.5, and 93.3%, respectively. The 3-year progression-free survival rates were 55.8, 11.8, and 41.9%, respectively. The rates were lowest for class C. The differences in the overall survival rate (p < 0.001) and progression-free survival rate (p = 0.001) were statistically significant. In advanced ovarian cancer patients, the presence of disease in the small-bowel serosa and mesentery results in poorer outcomes in terms of overall and progression-free survival. The number of patients with suboptimal cytoreduction was also highest in this group.

Entities:  

Keywords:  Advanced ovarian cancer; Epithelial ovarian cancers; Optimal cytoreduction; Pattern of spread; Survival

Year:  2017        PMID: 29887688      PMCID: PMC5984838          DOI: 10.1007/s13193-017-0618-5

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  27 in total

1.  Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.

Authors:  Elisabeth Chéreau; Marcos Ballester; Frédéric Selle; Annie Cortez; Emile Daraï; Roman Rouzier
Journal:  Am J Obstet Gynecol       Date:  2010-02       Impact factor: 8.661

Review 2.  Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Authors:  Ahmed Elattar; Andrew Bryant; Brett A Winter-Roach; Mohamed Hatem; Raj Naik
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

3.  Primary versus secondary cytoreduction for epithelial ovarian cancer: a paired analysis of tumour pattern and surgical outcome.

Authors:  Elena-Ioana Braicu; Jalid Sehouli; Rolf Richter; Klaus Pietzner; Werner Lichtenegger; Christina Fotopoulou
Journal:  Eur J Cancer       Date:  2011-07-13       Impact factor: 9.162

4.  Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.

Authors:  S M Eisenkop; R L Friedman; H J Wang
Journal:  Gynecol Oncol       Date:  1998-05       Impact factor: 5.482

5.  The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study.

Authors:  Chad A Hamilton; Austin Miller; Caela Miller; Thomas C Krivak; John H Farley; Mildred R Chernofsky; Michael P Stany; G Scott Rose; Maurie Markman; Robert F Ozols; Deborah K Armstrong; G Larry Maxwell
Journal:  Gynecol Oncol       Date:  2011-06-17       Impact factor: 5.482

6.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

7.  Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients.

Authors:  Seung-Hyuk Shim; Sun Joo Lee; Seon-Ok Kim; Soo-Nyung Kim; Dae-Yeon Kim; Jong Jin Lee; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  Gynecol Oncol       Date:  2014-11-09       Impact factor: 5.482

8.  A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

Authors:  Rudy S Suidan; Pedro T Ramirez; Debra M Sarasohn; Jerrold B Teitcher; Svetlana Mironov; Revathy B Iyer; Qin Zhou; Alexia Iasonos; Harold Paul; Masayoshi Hosaka; Carol A Aghajanian; Mario M Leitao; Ginger J Gardner; Nadeem R Abu-Rustum; Yukio Sonoda; Douglas A Levine; Hedvig Hricak; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2014-07-11       Impact factor: 5.482

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.

Authors:  Andrea E Wahner Hendrickson; Kieran M Hawthorne; Ellen L Goode; Kimberly R Kalli; Krista M Goergen; Jamie N Bakkum-Gamez; William A Cliby; Gary L Keeney; Daniel W Visscher; Yaman Tarabishy; Ann L Oberg; Lynn C Hartmann; Matthew J Maurer
Journal:  Gynecol Oncol       Date:  2015-01-22       Impact factor: 5.482

View more
  1 in total

1.  Small Bowel PCI Score as a Prognostic Factor of Ovarian Cancer Patients Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), a Retrospective Analysis of 130 Patients.

Authors:  Christos Iavazzo; Alexandros Fotiou; Victoria Psomiadou; Sofia Lekka; Dimitrios Katsanos; John Spiliotis
Journal:  Indian J Surg Oncol       Date:  2021-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.